User profiles for Mohammad Ehsanul Karim

Mohammad Ehsanul Karim

- Verified email at ubc.ca - Cited by 1512

Mohammad Ehsanul Karim

- Verified email at epfl.ch - Cited by 263

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell… - Jama, 2012 - jamanetwork.com
Context Interferon beta is widely prescribed to treat multiple sclerosis (MS); however, its
relationship with disability progression has yet to be established. Objective To investigate the …

A review: Can robots reshape K-12 STEM education?

ME Karim, S Lemaignan… - 2015 IEEE international …, 2015 - ieeexplore.ieee.org
Can robots in classroom reshape K-12 STEM education, and foster new ways of learning?
To sketch an answer, this article reviews, side-by-side, existing literature on robot-based …

[HTML][HTML] Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: a systematic …

…, N Ford, K Thorlund, AH Anis, ME Karim… - …, 2020 - thelancet.com
Background To inform World Health Organization (WHO) global guidelines, we updated and
expanded the evidence base to assess the comparative efficacy, tolerability, and safety of …

Comparison of statistical approaches for dealing with immortal time bias in drug effectiveness studies

…, M Ehsanul Karim… - American journal of …, 2016 - academic.oup.com
In time-to-event analyses of observational studies of drug effectiveness, incorrect handling of
the period between cohort entry and first treatment exposure during follow-up may result in …

A higher antibody response is generated with a 6-to 7-week (vs standard) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine dosing interval

…, PM Lavoie, ME Karim… - Clinical Infectious …, 2022 - academic.oup.com
The optimal dosing interval for severe acute respiratory syndrome coronavirus 2 vaccines
remains controversial. In this prospective study, we compared serology results of paramedics …

Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort

ME Karim, P Gustafson, J Petkau, Y Zhao… - American journal of …, 2014 - academic.oup.com
Longitudinal observational data are required to assess the association between exposure
to β-interferon medications and disease progression among relapsing-remitting multiple …

Correlation of SARS-CoV-2 viral neutralizing antibody titers with anti-spike antibodies and ACE-2 inhibition among vaccinated individuals

…, S Haig, V Barakauskas, ME Karim… - Microbiology …, 2022 - Am Soc Microbiol
SARS-CoV-2 anti-spike antibody concentrations and angiotensin converting enzyme-2 (ACE-2)
inhibition have been used as surrogates to live viral neutralizing antibody titers; however…

Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study

J Wilton, Y Abdia, M Chong, ME Karim, S Wong… - bmj, 2021 - bmj.com
Objective To assess the association between long term prescription opioid treatment
medically dispensed for non-cancer pain and the initiation of injection drug use (IDU) among …

[HTML][HTML] Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment

…, Y Zhao, J Petkau, P Gustafson, ME Karim… - BioMed research …, 2015 - hindawi.com
Background. We examined (1) patient characteristics and disease-modifying drug (DMD)
exposure in late-onset (LOMS, ≥50 years at symptom onset) versus adult-onset (AOMS, 18–<…

The relationship between anti-spike SARS-CoV-2 antibody levels and risk of breakthrough COVID-19 among fully vaccinated adults

…, DM Goldfarb, ME Karim… - The Journal of …, 2023 - academic.oup.com
The relationship between antibodies to wild-type severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) antigens and the risk of breakthrough infections is unclear, especially …